Your search found 15 records, sorted by year and then date of acquisition.

2. Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled Trial. doc type doc type
  Winhusen, Theresa M. ; Somoza, Eugene C. ; Brigham, Gregory S. ; Liu, David S. ; Green, Carla A. ; Covey, Lirio S. ; Croghan, Ivana T. ; Adler, Lenard A. ; Weiss, Roger D. ; Leimberger, Jeffrey D. ; Lewis, Daniel F. ; Dorer, Emily M.
 Journal of Clinical Psychiatry 2010;71(12):1680-1688. [doi: 10.4088/JCP.09m05089gry].
3. The First Decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the Gap Between Research and Practice to Improve Drug Abuse Treatment. doc type
  Tai, Betty ; Straus, Michele M. ; Liu, David S. ; Sparenborg, Steven ; Jackson, T. Ronald ; McCarty, Dennis
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S4-S13. [doi: 10.1016/j.jsat.2010.01.011].
4. From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network. doc type
  Ling, Walter ; Jacobs, Petra ; Hillhouse, Maureen P. ; Hasson, Albert L. ; Thomas, Christie ; Freese, Thomas E. ; Sparenborg, Steven ; McCarty, Dennis ; Weiss, Roger D. ; Saxon, Andrew J. ; Cohen, Allan J. ; Straus, Michele M. ; Brigham, Gregory S. ; Liu, David S. ; McLaughlin, Paul ; Tai, Betty
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60. [doi: 10.1016/j.jsat.2010.01.009].
5. NIDA's Clinical Trials Network Can Facilitate Comparative Effectiveness Research on Drug Addiction Treatments. doc type
  Ghitza, Udi E. ; Sparenborg, Steven ; Liu, David S. ; Tai, Betty
 Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
6. The National Drug Abuse Treatment Clinical Trials Network: Forging a Partnership between Research Knowledge and Community Practice. doc type
  Tai, Betty ; Sparenborg, Steven ; Liu, David S. ; Straus, Michele M.
 Substance Abuse and Rehabilitation 2011;2:21-28. [doi: 10.2147/SAR.S16756].
7. Randomized Controlled Trial of Osmotic-Release Methylphenidate with CBT in Adolescents with ADHD and Substance Use Disorders. doc type doc type
  Riggs, Paula D. ; Winhusen, Theresa M. ; Davies, Robert D. ; Leimberger, Jeffrey D. ; Mikulich-Gilbertson, Susan K. ; Klein, Constance ; Macdonald, Marilyn ; Lohman, Michelle ; Bailey, Genie L. ; Haynes, Louise F. ; Jaffee, William B. ; Hamilton, Nancy ; Hodgkins, Candace C. ; Whitmore, Elizabeth ; Trello-Rishel, Kathlene ; Tamm, Leanne ; Acosta, Michelle C. ; Royer-Malvestuto, Charlotte ; Subramaniam, Geetha A. ; Fishman, Marc J. ; Holmes, Beverly W. ; Kaye, Mary Elyse ; Vargo, Mark A. ; Woody, George E. ; Nunes, Edward V. ; Liu, David S.
 Journal of the American Academy of Child and Adolescent Psychiatry 2011;50(9):903-914. [doi: 10.1016/j.jaac.2011.06.010].
8. Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence: An Efficacy Trial Conducted in the Real World. doc type
  Winhusen, Theresa M. ; Brady, Kathleen T. ; Stitzer, Maxine L. ; Woody, George E. ; Lindblad, Robert ; Kropp, Frankie B. ; Brigham, Gregory S. ; Liu, David S. ; Sparenborg, Steven ; Sharma, Gaurav ; VanVeldhuisen, Paul C. ; Adinoff, Bryon H. ; Somoza, Eugene C.
 Contemporary Clinical Trials 2012;33(5):993-1002. [doi: 10.1016/j.cct.2012.05.003].
9. Expanding the National Drug Abuse Treatment Clinical Trials Network to Address the Management of Substance Use Disorders in General Medical Settings. doc type
  Tai, Betty ; Sparenborg, Steven ; Ghitza, Udi E. ; Liu, David S.
 Substance Abuse and Rehabilitation 2014;5:75-80. [doi: 10.2147/SAR.S66538].
10. Long-Term Outcomes After Randomization to Buprenorphine/Naloxone Versus Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Evans, Elizabeth ; Huang, David ; Weiss, Roger D. ; Saxon, Andrew J. ; Carroll, Kathleen M. ; Woody, George E. ; Liu, David S. ; Wakim, Paul G. ; Matthews, Abigail G. ; Hatch-Maillette, Mary A. ; Jelstrom, Eve ; Wiest, Katharina L. ; McLaughlin, Paul ; Ling, Walter
 Addiction 2016;111(4):695-705. [doi: 10.1111/add.13238].
11. Buprenorphine-Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Mooney, Larissa J. ; Thomas, Christie ; Ang, Alfonso ; Matthews, Abigail G. ; Hasson, Albert L. ; Annon, Jeffrey J. ; Sparenborg, Steven ; Liu, David S. ; McCormack, Jennifer ; Church, Sarah ; Swafford, William ; Drexler, Karen ; Schuman, Carolyn ; Ross, Stephen ; Wiest, Katharina L. ; Korthuis, P. Todd ; Lawson, William ; Brigham, Gregory S. ; Knox, Patricia C. ; Dawes, Michael ; Rotrosen, John
 Addiction 2016;111(8):1416-1427. [doi: 10.1111/add.13375].
12. NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale. doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bailey, Genie L. ; Brigham, Gregory S. ; Cohen, Allan J. ; Fishman, Marc J. ; Ling, Walter ; Lindblad, Robert ; Shmueli-Blumberg, Dikla ; Stablein, Don ; May, Jeanine ; Salazar, Dagmar ; Liu, David S. ; Rotrosen, John
 Contemporary Clinical Trials 2016;50:253-264. [doi: 10.1016/j.cct.2016.08.004].
13. Randomized Controlled Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results from the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) Study. doc type
  Trivedi, Madhukar H. ; Greer, Tracy L. ; Rethorst, Chad D. ; Carmody, Thomas ; Grannemann, Bruce D. ; Walker, N. Robrina ; Warden, Diane ; Shores-Wilson, Kathy ; Stoutenberg, Mark ; Oden, Neal L. ; Silverstein, Meredith ; Hodgkins, Candace ; Love, Lee D. ; Seamans, Cindy ; Stotts, Angela L. ; Causey, Trey ; Szucs-Reed, Regina P. ; Rinaldi, Paul ; Myrick, Hugh ; Straus, Michele ; Liu, David S. ; Lindblad, Robert ; Church, Timothy ; Blair, Steven N. ; Nunes, Edward V.
 Journal of Clinical Psychiatry 2017;78(8):1075-1082. [doi: 10.4088/JCP.15m10591].
14. Testing and Linkage to HIV Care in China: A Cluster-Randomised Trial. doc type
  Wu, Zunyou ; Tang, Zhenzhu ; Mao, Yurong ; VanVeldhuisen, Paul C. ; Ling, Walter ; Liu, David S. ; Shen, Zhiyong ; Detels, Roger ; Lan, Guanghua ; Erinoff, Lynda ; Lindblad, Robert ; Gu, Diane ; Tang, Houlin ; Hu, Lian ; Zhu, Qiuying ; Lu, Li ; Oden, Neal L. ; Hasson, Albert L. ; Zhao, Yan ; McGoogan, Jennifer M. ; Ge, Xianmin ; Zhang, Nanci ; Rou, Keming ; Zhu, Jinhui ; Wei, Hui ; Shi, Cynthia X. ; Jin, Xia ; Li, Jian ; Montaner, Julio S. G.
 Lancet HIV 2017;4(12):e555-e565. [doi: 10.1016/S2352-3018(17)30131-5].
15. Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicentre, Open-Label, Randomised Controlled Trial. doc type doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bachrach, Ken ; Bailey, Genie L. ; Bhatt, Snehal ; Farkas, Sarah ; Fishman, Marc J. ; Gauthier, Phoebe ; Hodgkins, Candace C. ; King, Jacquie ; Lindblad, Robert ; Liu, David S. ; Matthews, Abigail G. ; May, Jeanine ; Peavy, K. Michelle ; Ross, Stephen ; Salazar, Dagmar ; Schkolnik, Paul ; Shmueli-Blumberg, Dikla ; Stablein, Don ; Subramaniam, Geetha A. ; Rotrosen, John
 The Lancet 2018;391(10118):309-318. [doi: 10.1016/S0140-6736(17)32812-X].

Powered by DB/Text WebPublisher, from Inmagic WebPublisher PRO